Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is 47 366,47 ₴, with a 24-hour trading volume of 100,98B ₴. The asset's market cap is 42,23T ₴, after moving -0.02% in the last day.
Tokenized Eli Lilly And Co is trading at 47 195,58 ₴, with a tokenized market cap of 266,78M ₴ and a 24-hour trading volume of 98,39M ₴. The tokenized asset has moved -0.02% in the past 24 hours.